Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.


February 07, 2018

Recent data from Zambia’s 2016 cholera epidemic found that giving people just one of the currently-recommended two doses of the oral cholera vaccine was nearly 90 percent effective for adequate short-term protection during this outbreak.

January 19, 2017

NEW YORK, JANUARY 20, 2017—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) began a new clinical trial this week in Uzbekistan to develop a radically improved course of treatment for drug-resistant tuberculosis (DR-TB).

The trial aims to find a treatment regimen for DR-TB that is drastically shorter, more effective, and causes fewer side effects than the current treatment options.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

April 08, 2016

New York/Lusaka, Zambia—The largest cholera vaccination campaign ever began today in Zambia’s capital, Lusaka. International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is working in close collaboration with the Zambian Ministry of Health and the World Health Organization to vaccinate more than half a million people in the next two weeks to curb the outbreak that began in February in the city’s overcrowded township areas.